Score Overview
See the full market ranking β
Kiora Pharmaceuticals Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 12.06K to $ 0.00 and net income went from -$ 6M to -$ 10M. Revenue increased in 1 of those 5 years; net income in 3.
Kiora Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.64 | β |
1 Year2025-08-12 | $ 2.50 | 5.60% |
5 Years2021-08-12 | $ 622.80 | -99.58% |
10 Years2016-08-12 | $ 10.21K | -99.97% |
All Time2015-07-31 | $ 38.61K | -99.99% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-07-31 |
|---|---|---|---|---|---|
| Price | $ 2.64 | $ 2.50 | $ 622.80 | $ 10.21K | $ 38.61K |
| Return | β | 5.60% | -99.58% | -99.97% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 10M | $ 17M |
| 2024 | $ 16M | $ 3M | $ 26M |
| 2023 | $ 0.00 | -$ 12M | $ 2M |
| 2022 | $ 0.00 | -$ 13M | $ 5M |
| 2021 | $ 12.06K | -$ 13M | $ 7M |
| 2020 | $ 12.06K | -$ 6M | $ 1M |
| 2019 | $ 2M | -$ 7M | $ 3M |
| 2018 | $ 1M | -$ 10M | $ 8M |
| 2017 | $ 407.52K | -$ 13M | $ 7M |
| 2016 | $ 669.26K | -$ 13M | $ 3M |
| IPO2015 | -$ 8M | $ 8M |
Explore beyond KPRX
You're looking at Kiora Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score β 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.